Sustained effect of prasinezumab on Parkinson’s disease motor progression in the open-label extension of the PASADENA trial
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Sustained effect of prasinezumab on Parkinson’s disease motor progression in the open-label extension of the PASADENA trial ; volume:30 ; number:12 ; day:8 ; month:10 ; year:2024 ; pages:3669-3675 ; date:12.2024
Nature medicine ; 30, Heft 12 (8.10.2024), 3669-3675, 12.2024
- Creator
-
Pagano, Gennaro
Monnet, Annabelle
Reyes, Adriana
Ribba, Benjamin
Svoboda, Hanno
Kustermann, Thomas
Simuni, Tanya
Postuma, Ronald B.
Pavese, Nicola
Stocchi, Fabrizio
Brockmann, Kathrin
Smigorski, Krzysztof
Gerbaldo, Valentina
Fontoura, Paulo
Doody, Rachelle
Kerchner, Geoffrey A.
Brundin, Patrik
Marek, Kenneth
Bonni, Azad
Nikolcheva, Tania
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41591-024-03270-6
- URN
-
urn:nbn:de:101:1-2502252144017.361855307869
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pagano, Gennaro
- Monnet, Annabelle
- Reyes, Adriana
- Ribba, Benjamin
- Svoboda, Hanno
- Kustermann, Thomas
- Simuni, Tanya
- Postuma, Ronald B.
- Pavese, Nicola
- Stocchi, Fabrizio
- Brockmann, Kathrin
- Smigorski, Krzysztof
- Gerbaldo, Valentina
- Fontoura, Paulo
- Doody, Rachelle
- Kerchner, Geoffrey A.
- Brundin, Patrik
- Marek, Kenneth
- Bonni, Azad
- Nikolcheva, Tania
- SpringerLink (Online service)
Other Objects (12)
Neurodegeneration and Neuroinflammation in Parkinson’s Disease: a Self-Sustained Loop
Data-Driven Subtyping of Parkinson’s Using Acoustic Analysis of Sustained Vowels and Cluster Analysis: Findings in the Parkinson’s Voice Initiative Study
Rotigotine transdermal system for long-term treatment of patients with advanced Parkinson’s disease: results of two open-label extension studies, CLEOPATRA-PD and PREFER
Pathological pallidal beta activity in Parkinson’s disease is sustained during sleep and associated with sleep disturbance
Long-term, open-label, phase 3 study of rasagiline in Japanese patients with early Parkinson’s disease
Long-term safety and efficacy of open-label nabilone on sleep and pain in Parkinson´s Disease
Parkinson
Parkinson
Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study
Effectiveness of Safinamide over Mood in Parkinson’s Disease Patients: Secondary Analysis of the Open-label Study SAFINONMOTOR
Advanced Parkinson’s or “complex phase” Parkinson’s disease? Re-evaluation is needed
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Neurodegeneration and Neuroinflammation in Parkinson’s Disease: a Self-Sustained Loop
Data-Driven Subtyping of Parkinson’s Using Acoustic Analysis of Sustained Vowels and Cluster Analysis: Findings in the Parkinson’s Voice Initiative Study
Rotigotine transdermal system for long-term treatment of patients with advanced Parkinson’s disease: results of two open-label extension studies, CLEOPATRA-PD and PREFER
Pathological pallidal beta activity in Parkinson’s disease is sustained during sleep and associated with sleep disturbance
Long-term, open-label, phase 3 study of rasagiline in Japanese patients with early Parkinson’s disease
Long-term safety and efficacy of open-label nabilone on sleep and pain in Parkinson´s Disease
Parkinson
Parkinson
Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study
Effectiveness of Safinamide over Mood in Parkinson’s Disease Patients: Secondary Analysis of the Open-label Study SAFINONMOTOR
Advanced Parkinson’s or “complex phase” Parkinson’s disease? Re-evaluation is needed
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Neurodegeneration and Neuroinflammation in Parkinson’s Disease: a Self-Sustained Loop
Data-Driven Subtyping of Parkinson’s Using Acoustic Analysis of Sustained Vowels and Cluster Analysis: Findings in the Parkinson’s Voice Initiative Study
Rotigotine transdermal system for long-term treatment of patients with advanced Parkinson’s disease: results of two open-label extension studies, CLEOPATRA-PD and PREFER
Pathological pallidal beta activity in Parkinson’s disease is sustained during sleep and associated with sleep disturbance
Long-term, open-label, phase 3 study of rasagiline in Japanese patients with early Parkinson’s disease
Long-term safety and efficacy of open-label nabilone on sleep and pain in Parkinson´s Disease
Parkinson
Parkinson
Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study
Effectiveness of Safinamide over Mood in Parkinson’s Disease Patients: Secondary Analysis of the Open-label Study SAFINONMOTOR
Advanced Parkinson’s or “complex phase” Parkinson’s disease? Re-evaluation is needed